2013
DOI: 10.1111/his.12267
|View full text |Cite
|
Sign up to set email alerts
|

The evolving classification of soft tissue tumours – an update based on the new 2013 WHO classification

Abstract: The new World Health Organization (WHO) classification of soft tissue tumours was published in early 2013, almost 11 years after the previous edition. While the number of newly recognized entities included for the first time is fewer than that in 2002, there have instead been substantial steps forward in molecular genetic and cytogenetic characterization of this family of tumours, leading to more reproducible diagnosis, a more meaningful classification scheme and providing new insights regarding pathogenesis, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
1,148
1
26

Year Published

2014
2014
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 803 publications
(1,180 citation statements)
references
References 54 publications
(63 reference statements)
5
1,148
1
26
Order By: Relevance
“…New genetic and molecular data for established tumour types were included as they facilitated improved pathological definition and diagnosis. [2] Interestingly, tumours previously classified as "mixed-type liposarcoma" are now considered unusual examples of dedifferentiated liposarcoma.…”
Section: Discussionmentioning
confidence: 99%
“…New genetic and molecular data for established tumour types were included as they facilitated improved pathological definition and diagnosis. [2] Interestingly, tumours previously classified as "mixed-type liposarcoma" are now considered unusual examples of dedifferentiated liposarcoma.…”
Section: Discussionmentioning
confidence: 99%
“…However, the difference in age distribution and unique appearance raised concerns about this categorization. Currently, the new 4th edition of the WHO classification of Tumors of Soft Tissue and Bone created a provisional category combining SRMS with spindle cell rhabdomyosarcoma (which was also previously included under embryonal rhabdomyosarcoma) [22]. The basis for this recategorization appears to be mainly a result of morphologic overlap between these variants [2,8,13,15,17,23].…”
Section: Discussionmentioning
confidence: 99%
“…Since these early reports a total of 42 cases of SRMS have been described in the English literature of which 22 have occurred in adults (C18 years old) [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20]. From the limited number of cases of this rare malignancy, it appears that SRMS has a predilection for the extremities and the head and neck.…”
Section: Introductionmentioning
confidence: 99%
“…The clinical presentation of Langerhans cell histiocytosis may vary from a solitary lesion of bone to a fulminant systemic involvement (Hand-Schüller-Christian disease and Letterer-Siwe disease) [19]. The World Health Organization 2013 guidelines [6] prefer the use of the term Langerhans cell histiocytosis; however, the term eosinophilic granuloma often is used when the disease is limited to bone or lung. Bone involvement occurs in the majority of patients and can involve any bone of the body; monostotic disease is more common than polyostotic involvement.…”
Section: Discussion and Treatmentmentioning
confidence: 99%